Pharmacokinetics of human chorionic gonadotropin injection in obese and normal-weight women

Journal of Clinical Endocrinology and Metabolism

Volumn 99, Issue 4, 2014, Pages 1314-1321

  Shah, Divya K ^a,b,c   Missmer, Stacey A ^b   Correia, Katharine F B ^b   Ginsburg, Elizabeth S ^b  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; CHORIONIC GONADOTROPIN; FEMALE; HUMANS; IDEAL BODY WEIGHT; INJECTIONS, INTRAMUSCULAR; INJECTIONS, SUBCUTANEOUS; OBESITY; PILOT PROJECTS; SKINFOLD THICKNESS; YOUNG ADULT;

EID: 84898409267     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-4086     Document Type: Article

References (24)

1. Elkind-Hirsch KE, Bello S, Esparcia L, Phillips K, Sheiko A, Mc-Nichol M. Serum human chorionic gonadotropin levels are correlated with body mass index rather than route of administration in women undergoing in vitro fertilization-embryo transfer using human menopausal gonadotropin and intracytoplasmic sperm injection. Fertil Steril. 2001;75(4):700-704.
2. Sills ES, Drews CD, Perloe M, Kaplan CR, Tucker MJ. Periovulatory serum human chorionic gonadotropin (hCG) concentrations following subcutaneous and intramuscular nonrecombinant hCG use during ovulation induction: a prospective, randomized trial. Fertil Steril. 2001;76(2):397-399.
3. Mannaerts BM, GeurtsTB, OdinkJ. A randomized three-way crossover study in healthy pituitary-suppressed women to compare the bioavailability of human chorionic gonadotrophin (Pregnyl) after intramuscular and subcutaneous administration. Hum Reprod. 1998;13(6):1461-1464.
4. Carrell DT, Jones KP, Peterson CM, Aoki V, Emery BR, Campbell BR. Body mass index is inversely related to intrafollicular HCG concentrations, embryo quality and IVF outcome. Reprod Biomed Online. 2001;3(2):109-111.
5. Stelling JR, Chapman ET, Frankfurter D, Harris DH, Oskowitz SP, Reindollar RH. Subcutaneous versus intramuscular administration of human chorionic gonadotropin during an in vitro fertilization cycle. Fertil Steril. 2003;79(4):881-885.
6. Farrag A, Costantini A, Manna C, Grimaldi G. Recombinant HCG for triggering ovulation increases the rate of mature oocytes in women treated for ICSI. J Assist Reprod Genet. 2008;25(9-10): 461-466.
7. The European Recombinant Human Chorionic Gonadotrophin Study Group. Induction of final follicular maturation and early lu-teinization in women undergoing ovulation induction for assisted reproduction treatment-recombinant HCG versus urinary HCG. Hum Reprod. 2000;15(7):1446-1451.
8. Al-Inany HG, Aboulghar M, Mansour R, Proctor M. Recombinant versus urinary human chorionic gonadotrophin for ovulation induction in assisted conception. Cochrane Database Syst Rev. 2005(2):CD003719.
9. Driscoll GL, Tyler JP, Hangan JT, Fisher PR, Birdsall MA, Knight DC. A prospective, randomized, controlled, double-blind, double-dummy comparison of recombinant and urinary HCG for inducing oocyte maturation and follicular luteinization in ovarian stimulation. Hum Reprod. 2000;15(6):1305-1310.
10. Hanley MJ, Abernethy DR, Greenblatt DJ. Effect of obesity on the pharmacokinetics of drugs in humans. Clin Pharmacokinet. 49(2): 71-87.
11. Gray DS, Fujioka K. Use of relative weight and body mass index for the determination of adiposity. J Clin Epidemiol. 1991;44(6):545-550.
12. Chan CC, Ng EH, Chan MM, et al. Bioavailability of hCG after intramuscular or subcutaneous injection in obese and non-obese women. Hum Reprod. 2003;18(11):2294-2297.
13. Harris ID, Python J, Roth L, Alvero R, Murray S, Schlaff WD. Physicians' perspectives and practices regarding the fertility management of obese patients. Fertil Steril. 2011;96(4):991-992.
14. Chang P, Kenley S, Burns T, et al. Recombinant human chorionic gonadotropin (rhCG) in assisted reproductive technology: results of a clinical trial comparing two doses of rhCG (Ovidrel) to urinary hCG (Profasi) for induction of final follicular maturation in in vitro fertilization-embryo transfer. Fertil Steril. 2001;76(1):67-74.
15. Maheshwari A, Stofberg L, Bhattacharya S. Effect of overweight and obesity on assisted reproductive technology-a systematic review. Hum Reprod Update. 2007;13(5):433-444.
16. Shah DK, Missmer SA, Berry KF, Racowsky C, Ginsburg ES. Effect of obesity on oocyte and embryo quality in women undergoing in vitro fertilization. Obstet Gynecol. 2011;118(1):63-70.
17. Rosencrantz MA, Coffler MS, Haggan A, et al. Clinical evidence for predominance of 5-5 steroid production in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2011;96(4):1106-1113.
18. Barnes RB, RosenfieldRL, BursteinS, Ehrmann DA. Pituitary-ovarian responses to nafarelin testing in the polycystic ovary syndrome. NEngl J Med. 1989;320(9):559-565.
19. Rosenfield RL, Barnes RB, Ehrmann DA. Studies of the nature of 17-hydroxyprogesterone hyperresonsiveness to gonadotropin-re-leasing hormone agonist challenge in functional ovarian hyperan-drogenism. J Clin Endocrinol Metab . 1994;79(6):1686-1692.
20. NisbetAC. Intramuscular gluteal injections in the increasingly obese population: retrospective study. BMJ. 2006;332(7542):637-638.
21. Zaybak A, Gunes UY, Tamsel S, Khorshid L, Eser I. Does obesity prevent the needle from reaching muscle in intramuscular injections? JAdv Nurs. 2007;58(6):552-556.
22. Kahraman S, Karlikaya G, Kavrut M, Karagozoglu H. A prospective, randomized, controlled study to compare two doses of recom-binant human chorionic gonadotropin in serum and follicular fluid in woman with high body mass index. Fertil Steril. 2010;93(6): 2084-2087.
23. Abdalla HI, Ah-Moye M, Brinsden P, Howe DL, Okonofua F, Craft I. The effect of the dose of human chorionic gonadotropin and the type of gonadotropin stimulation on oocyte recovery rates in an in vitro fertilization program. Fertil Steril. 1987;48(6):958-963.
24. Eliassen AH, Missmer SA, Tworoger SS, et al. Endogenous steroid hormone concentrations and risk of breast cancer among premeno-pausal women. J Natl Cancer Inst. 2006;98(19):1406-1415.